Krsnaa Diagnostics

Krsnaa Diagnostics EBIT per Share

The EBIT per Share of Krsnaa Diagnostics (KRSNAA.NS) as of Oct 31, 2026 is 50.16 INR. In the previous year, EBIT per Share was 31.63 INR — a change of 58.61% (higher).

EBIT per Share

50.16INR

YoY

58.61%

Last updated:

EBIT per Share of Krsnaa Diagnostics is 2026 50.16 INR. EBIT per Share of Krsnaa Diagnostics was 2025 31.63 INR. It decreases by 58.61% higher compared to the previous year.

The Krsnaa Diagnostics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2024
21.56 INR
Jan 1, 2025
31.63 INR
Jan 1, 2026
50.16 INR
Jan 1, 2027 (e)
70.54 INR
Jan 1, 2028 (e)
91.08 INR
Jan 1, 2029 (e)
57.16 INR
Jan 1, 2030 (e)
68.15 INR
Jan 1, 2031 (e)
80.56 INR
The Krsnaa Diagnostics EBIT per Share history
YEAREBIT per ShareYoY
est80.56INR+18.20%
est68.15INR+19.24%
est57.16INR-37.25%
est91.08INR+29.12%
est70.54INR+40.62%
50.16INR+58.61%
31.63INR+46.69%
21.56INR-18.40%
26.42INR-6.49%
28.26INR+43.86%
19.64INR-33.30%
29.45INR+199.59%
9.83INR+119.84%
4.47INR+215.10%
1.42INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

EBIT per Share of Krsnaa Diagnostics is 50.16 INR in 2026.

EBIT per Share of Krsnaa Diagnostics changed from 31.63 INR to 50.16 INR, representing a 58.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Krsnaa Diagnostics

All Key Metrics — Krsnaa Diagnostics